Dyadic International, Inc.
NASDAQ:DYAIBiotechnology
+$0.26 today
- Market cap
- $53.56M
- Beta
- 1.15
- P/E (TTM)
- -6.9
- EPS (TTM)
- -$0.20
Volume 0.71M
Average 0.31M
DYAI Total Liabilities
Everything the company owes to creditors and other parties.
Dyadic International, Inc.NASDAQ: DYAI
Total Liabilities · Q1 FY2026 · quarter ended Mar 2026
Total liabilities rises 17.9% from a year ago
Total liabilities stood at $8.22M at the end of Q1 FY2026, up 17.9% from a year earlier and down 5.7% from the prior quarter. Over 3 fiscal years it compounded at +49.2% a year.
Context
- Total liabilities amounted to 105.2% of total assets at the end of Q1 FY2026, up 16.9 pp from a year earlier.
- Total liabilities increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total liabilities keeps rising in the next quarterly balance sheet after a +17.9% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 8.71M USD
- Year-over-year change
- +16.8%
- 4-year CAGR
- +31.6%
| Period | Period end | Total Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 8.71M | +16.8% |
| FY2024 | 2024-12-31 | 7.46M | +218.7% |
| FY2023 | 2023-12-31 | 2.34M | -10.8% |
| FY2022 | 2022-12-31 | 2.63M | -9.7% |
| FY2021 | 2021-12-31 | 2.91M | — |
Total Liabilities vs competitors
How DYAI compares with its peers on the latest reported figures
- Peers report in different currencies, so total liabilities is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +17.9% is the 2nd highest of 8, against a peer median of -4.1%.
- Total liabilities amounts to 105.2% of total assets for DYAI, versus a peer median of 21.4%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Dec 2025 | $145.39M USD | +17.4% | -10.4% | 135.5% | |
| Mar 2026 | $13.12M USD | +388.9% | -18.1% | 80.8% | |
| Mar 2026 | $10.38M USD | -38.1% | -17.4% | 54.2% | |
| Mar 2026 | $8.3M USD | -28.6% | -39.7% | 19.3% | |
| Mar 2026 | $8.22M USD | +17.9% | +49.2% | 105.2% | |
| Mar 2026 | $7.56M USD | +9.2% | +27.8% | 21.4% | |
| Mar 2026 | $2.7M USD | -5.5% | +34.4% | 19.3% | |
| Dec 2025 | A$2.65M AUD | -4.1% | -15.0% | 4.7% | |
| Peer median (excluding DYAI) | — | -4.1% | -15.0% | 21.4% | |
Competitors are the stored peer set for DYAI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 15.75M | 5.79M | 6.52M | 6.51M | 4.62M |
| Short-term Investments | 4.51M | 6.85M | 748.29K | 2.76M | 2.7M |
| Net Receivables | 372.21K | 330K | 466.16K | 237.03K | 1.13M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 58.29K | 10.08K | 24.25K | 1.23M |
| Total Current Assets | 21.01M | 13.42M | 8.07M | 9.83M | 9.9M |
| Property, Plant & Equipment (Net) | 0 | 0 | 141.44K | 92.21K | 38.54K |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 284.71K | 284.71K | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 6.12K | 6.05K | 10.46K | 10.4K | 10.54K |
| Total Non-current Assets | 290.83K | 290.75K | 151.9K | 102.61K | 49.07K |
| Total Assets | 21.3M | 13.71M | 8.22M | 9.93M | 9.95M |
| Account Payables | 1.55M | 1.28M | 656.45K | 482.32K | 852.02K |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 147.06K | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 151.15K | 217.21K | 490.11K | 833.81K | 2.13M |
| Total Current Liabilities | 2.56M | 2.45M | 2.25M | 2.45M | 3.69M |
| Long-term Debt | 0 | 0 | 0 | 4.98M | 5.03M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 352.94K | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 176.47K | 0 | 0 | 0 |
| Total Non-current Liabilities | 352.94K | 176.47K | 88.87K | 5.01M | 5.03M |
| Total Liabilities | 2.91M | 2.63M | 2.34M | 7.46M | 8.71M |
| Common Stock | 40.48K | 40.82K | 41.07K | 42.09K | 48.44K |
| Retained Earnings | (63.75M) | (73.48M) | (80.28M) | (86.09M) | (93.45M) |
| Accumulated OCI | 0 | (0) | (0) | (0) | (0) |
| Other Stockholders Equity | (0) | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 18.39M | 11.09M | 5.88M | 2.47M | 1.23M |
| Total Debt | 0 | 0 | 136.93K | 5.07M | 5.06M |
| Net Debt | (15.75M) | (5.79M) | (6.38M) | (1.44M) | 438.33K |
Dyadic International, Inc.
NASDAQ:DYAI
Intrinsic Alpha fair value
Locked
Current Price
$1.47
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.